BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23581412)

  • 1. Terbinafine inhibits KSR1 and suppresses Raf-MEK-ERK signaling in oral squamous cell carcinoma cells.
    Li B; Lu L; Zhong M; Tan XX; Liu CY; Guo Y; Yi X
    Neoplasma; 2013; 60(4):406-12. PubMed ID: 23581412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nm23-H1 metastasis suppressor expression level influences the binding properties, stability, and function of the kinase suppressor of Ras1 (KSR1) Erk scaffold in breast carcinoma cells.
    Salerno M; Palmieri D; Bouadis A; Halverson D; Steeg PS
    Mol Cell Biol; 2005 Feb; 25(4):1379-88. PubMed ID: 15684389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
    Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E
    Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced susceptibility to apoptosis of oral squamous cell carcinoma cells subjected to combined treatment with anticancer drugs and phosphatidylinositol 3-kinase inhibitors.
    Iwase M; Yoshiba S; Uchid M; Takaoka S; Kurihara Y; Ito D; Hatori M; Shintani S
    Int J Oncol; 2007 Nov; 31(5):1141-7. PubMed ID: 17912441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terbinafine inhibits oral squamous cell carcinoma growth through anti-cancer cell proliferation and anti-angiogenesis.
    Chien MH; Lee TS; Kao C; Yang SF; Lee WS
    Mol Carcinog; 2012 May; 51(5):389-99. PubMed ID: 21563217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
    Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W
    J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway.
    Gollob JA; Wilhelm S; Carter C; Kelley SL
    Semin Oncol; 2006 Aug; 33(4):392-406. PubMed ID: 16890795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of kinase suppressor of Ras1 enhances cisplatin-induced extracellular signal-regulated kinase activation and cisplatin sensitivity.
    Kim M; Yan Y; Kortum RL; Stoeger SM; Sgagias MK; Lee K; Lewis RE; Cowan KH
    Cancer Res; 2005 May; 65(10):3986-92. PubMed ID: 15899786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2.
    Chang CM; Chang PY; Tu MG; Lu CC; Kuo SC; Amagaya S; Lee CY; Jao HY; Chen MY; Yang JS
    Oncol Rep; 2012 Nov; 28(5):1799-807. PubMed ID: 22923287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electromagnetic fields at mobile phone frequency induce apoptosis and inactivation of the multi-chaperone complex in human epidermoid cancer cells.
    Caraglia M; Marra M; Mancinelli F; D'Ambrosio G; Massa R; Giordano A; Budillon A; Abbruzzese A; Bismuto E
    J Cell Physiol; 2005 Aug; 204(2):539-48. PubMed ID: 15754340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
    Yang R; Piperdi S; Gorlick R
    Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined cetuximab and genistein treatment shows additive anti-cancer effect on oral squamous cell carcinoma.
    Park SJ; Kim MJ; Kim YK; Kim SM; Park JY; Myoung H
    Cancer Lett; 2010 Jun; 292(1):54-63. PubMed ID: 19959278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terbinafine stimulates the pro-inflammatory responses in human monocytic THP-1 cells through an ERK signaling pathway.
    Mizuno K; Fukami T; Toyoda Y; Nakajima M; Yokoi T
    Life Sci; 2010 Oct; 87(17-18):537-44. PubMed ID: 20816994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of extracellular signal-regulated protein kinase and lymphnode metastasis in oral squamous cell carcinoma].
    Wang QX; Shen L; Sun CF
    Shanghai Kou Qiang Yi Xue; 2005 Feb; 14(1):18-20. PubMed ID: 15747007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cells.
    Ma Y; Yu WD; Kong RX; Trump DL; Johnson CS
    Cancer Res; 2006 Aug; 66(16):8131-8. PubMed ID: 16912191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
    Gysin S; Lee SH; Dean NM; McMahon M
    Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2.
    Lee M
    Biochem Biophys Res Commun; 2006 Nov; 350(2):450-6. PubMed ID: 17010316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Telomerase SiRNA inhibits KB cell growth in human oral squamous cell carcinoma].
    Yang ZQ; Chen GS; Chen JK; Wu ZL; Lei YX
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Sep; 39(5):376-8. PubMed ID: 15498341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced sensitivity of human oral carcinomas to induction of apoptosis by selenium compounds: involvement of mitogen-activated protein kinase and Fas pathways.
    Ghose A; Fleming J; El-Bayoumy K; Harrison PR
    Cancer Res; 2001 Oct; 61(20):7479-87. PubMed ID: 11606383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.